Fig. 4From: Sevoflurane inhibits the progression of ovarian cancer through down-regulating stanniocalcin 1 (STC1)Sevoflurane reduces the migration and invasion abilities of ovarian cancer cells. a Images and wound closure percentage of SKOV3 and OVCAR3 cells for 24 h after sevoflurane treatment. b, c Transwell assays were used to detect cell migration (b) and invasion (c) in sevoflurane-treated SKOV3 and OVCAR3 cells. The data were expressed as the mean ± SD from three independent experiments. *P < 0.05 vs. the negative control groupBack to article page